INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2013

A review indicates that the synthetic sweetener sucralose is not biologically inert and can alter metabolic, gut, and chemical endpoints.

This review summarizes biological issues associated with the synthetic sweetener sucralose. Findings show that sucralose interacts with alimentary chemosensors and, in both human and rodent studies, may alter glucose, insulin, and glucagon-like peptide 1 (GLP-1) levels. Animal studies demonstrate increased intestinal expression of P-gp and two CYP isozymes, altered gut microbial composition, and evidence of gastrointestinal metabolism into unidentified metabolites. Additionally, sucralose and a hydrolysis product were mutagenic at elevated concentrations in several tests, and cooking at high temperatures generated potentially toxic chloropropanols.

Study type
Narrative review
Who was studied
Human and rodent studies
What was measured
Biological effects of sucralose, including gut microbiota, drug metabolism, metabolism, mutagenicity, and thermal degradation

THE PAPER

Sucralose, a synthetic organochlorine sweetener: overview of biological issues.

Schiffman SS, Rother KI. J Toxicol Environ Health B Crit Rev, 2013.

PubMed 24219506 ↗DOI 10.1080/10937404.2013.842523 ↗

Diabetes & blood sugarGut & microbiomeFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.